Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 31693429

Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2020 Jan 10
First author
Sehn LH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2020 Jan 10;38(2):166-168. doi: 10.1200/JCO.19.02587.
    note
    Source null
    related pmid
    31770050
    relationship
    Comment in
  2. citation
    Br J Haematol. 2020 Jun;189(6):e248-e251. doi: 10.1111/bjh.16679.
    note
    Source null
    related pmid
    32342503
    relationship
    Comment in

Authors and identifiers

  1. name
    Sehn LH
    type
    Author
  2. name
    Herrera AF
    type
    Author
  3. name
    Flowers CR
    type
    Author
  4. name
    Kamdar MK
    type
    Author
  5. name
    McMillan A
    type
    Author
  6. name
    Hertzberg M
    type
    Author
  7. name
    Assouline S
    type
    Author
  8. name
    Kim TM
    type
    Author
  9. name
    Kim WS
    type
    Author
  10. name
    Ozcan M
    type
    Author
  11. name
    Hirata J
    type
    Author
  12. name
    Penuel E
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Sehn LH
    type
    Author
  2. name
    Herrera AF
    type
    Author
  3. name
    Flowers CR
    type
    Author
  4. name
    Kamdar MK
    type
    Author
  5. name
    McMillan A
    type
    Author
  6. name
    Hertzberg M
    type
    Author
  7. name
    Assouline S
    type
    Author
  8. name
    Kim TM
    type
    Author
  9. name
    Kim WS
    type
    Author
  10. name
    Ozcan M
    type
    Author
  11. name
    Hirata J
    type
    Author
  12. name
    Penuel E
    type
    Author
bibliography ids
  1. nci-bib-5a0501a3ff3aae4adbf01fe7
book metadata
content sha256
9cc83ad1bc649d7ac4e1446bf7b0482a5903269afea10d89c3cc5072a68768bc
document type
citation
dois
  1. 10.1200/JCO.19.00172
electronic publication date
display
2019 Nov 6
precision
day
year
2019
evidence scope
bibliographic_metadata_only
id
pubmed:31693429
immutable id
pubmed:31693429@9cc83ad1bc649d7ac4e1446bf7b0482a5903269afea10d89c3cc5072a68768bc
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
2
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
155-165
volume
38
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2020 Jan 10;38(2):166-168. doi: 10.1200/JCO.19.02587.
    note
    Source null
    related pmid
    31770050
    relationship
    Comment in
  2. citation
    Br J Haematol. 2020 Jun;189(6):e248-e251. doi: 10.1111/bjh.16679.
    note
    Source null
    related pmid
    32342503
    relationship
    Comment in
outcomes validated
false
pmid
31693429
provenance
batch id
4c5003fbb78890e89ae1
provider
NCBI PubMed ESummary
record sha256
d72270de99d3403b2d9aa84c2b9fbd45c5e40fb329c8d88ae869a653f1d6dd07
response sha256
890389583ce193a9c74e19c63678e418dad2088e82cb704b888b02fcc887d269
retrieved at
2026-09-09T23:47:48.270700+00:00
publication date
display
2020 Jan 10
precision
day
year
2020
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/31693429/
title
Polatuzumab Vedotin in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.

Preserved source evidence · Independent clinical review pending · Not medical advice